Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 130-141
Open Access | Times Cited: 72

Showing 26-50 of 72 citing articles:

The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, et al.
Rheumatology International (2024) Vol. 44, Iss. 8, pp. 1487-1499
Open Access | Times Cited: 1
Swimming exercise alleviates pathological bone features in curdlan-injected SKG mice by inducing irisin expression
Seung Hoon Lee, Bora Nam, Jeehee Youn, et al.
Life Sciences (2024) Vol. 352, pp. 122894-122894
Closed Access | Times Cited: 1
Biological therapy for psoriatic arthritis: current state and future perspectives
Dominika Boboryko, Joanna Olejnik-Wojciechowska, Magdalena Baranowska, et al.
Rheumatology International (2024)
Closed Access | Times Cited: 1
Xinfeng capsule inhibits lncRNA NONHSAT227927.1/TRAF2 to alleviate NF-κB-p65-induced immuno-inflammation in ankylosing spondylitis
Yanyan Fang, Jian Liu, Ling Xin, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117677-117677
Closed Access | Times Cited: 4
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases
Markus F. Neurath, Leslie J. Berg
Trends in Immunology (2024) Vol. 45, Iss. 8, pp. 580-596
Open Access | Times Cited: 1
Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study
Oh Chan Kwon, Hye Sun Lee, Juyeon Yang, et al.
Clinical Rheumatology (2024) Vol. 44, Iss. 1, pp. 257-266
Closed Access | Times Cited: 1
Predictive Values of Blood Type I and Type II Interferon Production for Disease Activity and Clinical Response to TNF-<i>α</i> Blocking Therapy in Patients with Ankylosing Spondylitis
Yulan Hu, Bo Lou, Zhonghua Jiang, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 260, Iss. 3, pp. 263-271
Open Access | Times Cited: 3
Advances in pharmacotherapies for axial spondyloarthritis
Éric Toussirot
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 13, pp. 1439-1448
Closed Access | Times Cited: 3
Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
Rubén Queiró, Elena Aurrecoechea, Sara Alonso-Castro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis
Erye Zhou, Jian Wu, Keqin Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
B. Farisoğulları, Eduardo Santos, Emma Dures, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e003349-e003349
Open Access | Times Cited: 3
Predictive values of circulating miR‐146a and miR‐155 for disease activity and clinical response to TNF‐α blocking therapy in patients with ankylosing spondylitis
Ling Liu, X. Hu
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 3
Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center
Einat Savin, Niv Ben‐Shabat, Asaf Levartovsky, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7151-7151
Open Access | Times Cited: 2
CCL20 inhibition for treating inflammation in ankylosing spondylitis
Eun Jeong Won, Hui-Ju Kim, Yu Jeong Lee, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 12, pp. 4000-4005
Closed Access | Times Cited: 2
Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice
Casper Webers, Rabab Nezam El-Din, Esther Beckers, et al.
Lara D. Veeken (2023) Vol. 64, Iss. 1, pp. 91-98
Open Access | Times Cited: 2
Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database
Shuang Xia, Yunfei Li, Emanuel Raschi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Sophoridine exerts anti‐arthritic effects on fibroblast‐like synoviocytes and collagen‐induced arthritis in rats
G Chen, Yehua Xia, Xiaotian Shi, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3337-3351
Closed Access
Thoracic manifestations and respiratory function alterations in axial spondyloarthritis and newest possibilities of ultrasound to detect changes in diaphragm—a narrative review
Hana Skala Kavanagh, Jan Aksentijević, Frane Grubišić, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 3441-3449
Open Access
Antidrug Antibody, Therapeutic Drug Monitoring: Status Update and Future Directions in Spondyloarthritis
Dae‐Hyun Yoo
Arthritis & Rheumatology (2024) Vol. 76, Iss. 12, pp. 1699-1701
Closed Access
Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS)
Kavita Makan, Marco Garrido‐Cumbrera, R Du Toit, et al.
Clinical Rheumatology (2024)
Open Access
Efficacy and safety of mind-body exercise for patients with axial spondyloarthritis: a systematic review and meta-analysis
Jing Wang, X. Li, Fangjie Yang, et al.
Journal of Orthopaedic Surgery and Research (2024) Vol. 19, Iss. 1
Open Access
The Effect of Therapeutic Exercise and Local Cryotherapy on Lower Limb Enthesitis in Non-Radiographic Axial Spondyloarthritis: A Case Report
Angelo Alito, Rossella Talotta, Valeria D’Amico, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1035-1035
Open Access
Experiences and perceptions of patients with ankylosing spondylitis: A systematic review and meta-synthesis of qualitative studies
Yu Li, Dongchi Ma, Lili Yang
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0311798-e0311798
Open Access
How Are We Addressing Axial Psoriatic Arthritis in Clinical Practice?
Xabier Michelena, Clementina López‐Medina, Eugenio de Miguel, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 6, pp. 1441-1456
Open Access

Scroll to top